[324 Pages Report] The global ursolic market is estimated to be valued at US$ 8.6 Mn in 2022, and is expected to cross US$ 13.2 Mn by 2032 with a CAGR of 5.4% during the forecast period.
Demand for ursolic acid is projected to rise due to its anti-depressant qualities. Furthermore, the adoption of ursolic acid increases as it is an essential nutrient requirement to counteract age-related changes. The ursolic acid market size is anticipated to expand owing to its ability to enhance the formation of ceramics in the skin.
| Attributes | Details |
|---|---|
| Ursolic Acid Market Size (2022) | US$ 8.6 Million |
| Ursolic Acid Market Size (2032) | US$ 13.2 Million |
| Ursolic Acid Market CAGR | 5.4% |
Consumer preference for natural and organic products owing to growing health awareness increases the sales of ursolic acid. The growing trend of natural ingredients in cosmetic products, rising the demand for “clean” makeup, escalates the ursolic acid market trends.
Manufacturers concentrating on acquiring local and regional companies to strengthen their supply chain owing to easy availability of raw materials, broadens the ursolic acid market share.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Demand for ursolic acid is rising owing to the high prevalence of cardiovascular diseases amongst individuals. Increasing demand for acquiring lean muscles surges the adoption of ursolic acid in dietary supplements.
Research and published studies to develop and showcase the benefits of ursolic acid capsules is anticipated to boost the requirement for functional foods and beverages to acquire muscle and bone growth. As a result, this factor drives the sales of ursolic acid.
Demand for ursolic acid surges due to its antimicrobial, anti-diabetic, and anti-inflammatory properties. Furthermore, the transition from small molecules to nano-drug delivery systems expands the ursolic acid market size.
The adoption of ursolic acid is further applied to the production of supplements and capsules aiding in fat mass reduction. Moreover, the R&D activities extracting the advantages of ursolic acid owing to its therapeutic actions in cancer therapy, boosting the demand for ursolic acid.
The ability to reduce cancer cell growth as a promising chemotherapeutic agent increases the sales of ursolic acid. The utilisation of ursolic acid in the cosmetic industry bolsters the ursolic acid market growth.
Rapid urbanisation and disposable income amongst the working-class population elevates the ursolic acid market share. Pharmaceutical companies increasing their research in molecular modelling approaches to develop drug designs that can treat COVID-19, propels the demand for ursolic acid.
Lack of awareness about the use and benefits of ursolic acid in under-developed countries, along with the availability of alternatives in the market initiating a switch in consumer preference hinders the sales of ursolic acid.
Excess use of ursolic acid causing side effects such as DNA damage, and reducing reproductive capacity such as deteriorated sperm mortality, curbs the demand for ursolic acid.
Other side effects including nausea, stomach swelling, increased sodium levels, skin rash, etc. along with the pandemic, disrupted the distribution and supply chain, further restraining the ursolic acid market share.
Principal Consultant
The growth of nutraceutical and functional food based products, increasing the availability of ursolic acid capsules in glass bottles expands the ursolic acid market size. Stearate-free ursolic acid capsules supporting the development of lean muscles, creates novelty in the health & nutrition sector, further propelling the adoption of ursolic acid.
The obtainability of ursolic acid from plants saving production cost, bolsters the ursolic acid market growth. Pharmaceutical companies acquiring their sources from the juice industry fruit wastes, and launching products with proven health benefits incorporating ursolic acid in the products, escalate the demand for ursolic acid.
North America is the leading region of the ursolic acid market share, garnering a CAGR of 33.2%. This is owing to the rise in fitness activities and healthcare concerns. Furthermore, the demand for natural cosmetic and food products in this region further propels the ursolic acid market growth.
Online and e-commerce platforms aiding in the accessibility of the product, extends the ursolic acid market share. Advancements and technical innovations in the pharmaceutical field further propels the sales of ursolic acid.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
The Asia-Pacific is the second leading region projection a large revenue share of 28%. Rising health concern and increasing cases of cardiovascular diseases amongst the population fuels market growth. Consumption volumes and increasing number of production sites, increasing disposable income of the middle-class population and the trend of herbal products fuelling the market expands the ursolic acid market size.
Food safety and security are becoming more important concerns for East Asian consumers, both domestically and internationally, as a result of food scandals. As a result, the popularity of natural and healthful components has grown in recent years.
Europe is a growing ursolic acid market share with a revenue of 26.8%Rapid urbanisation and demand for natural ingredients in cosmetics, food and beverages in this region contributes to the europe ursolic acid market growth.
The adoption of ursolic acid increases owing to the awareness about plant-derived biologically active products. Decreasing radio resistance in patients permitting the prevention of chronic diseases surges the ursolic acid market size.
The multiple biological activities of ursolic acid present a lucrative opportunity for market players. The anti-inflammatory, antioxidant, anti-cancer, etc. properties of ursolic acid provide startups in ursolic market to generate more versatile applications for ursolic acid.
The major focus for players in the ursolic acid market is its effectiveness on cancer. Patients experience a smooth recovery from chemotherapy owing to the use of ursolic acid.
To overcome the disadvantages of ursolic acid such as poor bioavailability and absorption, researchers around the globe are aiding start-up companies by designing and developing synthetic ursolic acid derivatives with enhanced therapeutic effects. This is done by structurally altering the parent skeleton of ursolic acid.
Some of the key participants of the ursolic acid market are Sabinsa, Sami Labs, Changsha Staherb Natural Ingredients, Changsha Luyuan Bio-Tech, Run Shaanxi Days of Bio-tech, Shaanxi Hopeland Chem-Tech, Shaanxi Huike Botanical Development, , Xuancheng Baicao Pharmaceutical, Acetar Bio-Tech, Changsha E.K HERB, Shaanxi Jintai Biological Engineering, Hunan NutraMax, Xi’an TonKing, Zhangjiajie Hengxing Biological Technology, MicroHerb, Geneham Pharmaceutical.
Owing to the various application possibilities of ursolic acid, key manufacturers are trying to churn out more areas of utilization of the product considering its extremely potent health benefits.
The availability of food waste, especially fruit wastes and scraps discarded in the juice industries – not only provides an eco-friendly, but economical approach which fuels the ursolic acid market growth during the forecast period.
Recent Developments in the Ursolic Acid Market:
| Report Attribute | Details |
|---|---|
| Growth Rate | CAGR of 5.4% from 2022 to 2032 |
| Base year for estimation | 2021 |
| Historical data | 2016 to 2021 |
| Forecast period | 2022 to 2032 |
| Quantitative units | Revenue in USD million and CAGR from 2022 to 2032 |
| Report coverage | Revenue forecast, volume forecast, company ranking, competitive landscape, growth factors, and trends, Pricing Analysis, |
| Segments covered | Type, Application, and Region. |
| Regional scope | North America; Western Europe, Eastern Europe, Middle East, Africa, ASEAN, South Asia, Rest of Asia, Australia and New Zealand |
| Country scope | USA; Canada; Mexico; Germany; UK; France; Italy; Spain; Russia; Belgium; Poland; Czech Republic; China; India; Japan; Australia; Brazil; Argentina; Colombia; Saudi Arabia; UAE; Iran; South Africa |
| Key companies profiled | Sabinsa, Sami Labs, Changsha Staherb Natural Ingredients, Changsha Luyuan Bio-Tech, Run Shaanxi Days of Bio-tech, Shaanxi Hopeland Chem-Tech, Shaanxi Huike Botanical Development, , Xuancheng Baicao Pharmaceutical, Acetar Bio-Tech, Changsha E.K HERB, Shaanxi Jintai Biological Engineering, Hunan NutraMax, Xi’an TonKing, Zhangjiajie Hengxing Biological Technology, MicroHerb, Geneham Pharmaceutical. |
| Customization scope | Free report customization (equivalent to up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope. |
| Pricing and purchase options | Avail customized purchase options to meet your exact research needs. |
The ursolic acid market is likely to garner a CAGR of 5.4% during the forecast period.
The market is likely to gather a revenue of about US$ 13.2 Mn, by 2032.
North America is the leading market for ursolic acid.
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Product Life Cycle Analysis
3.5. Supply Chain Analysis
3.5.1. Supply Side Participants and their Roles
3.5.1.1. Producers
3.5.1.2. Mid-Level Participants (Traders/ Agents/ Brokers)
3.5.1.3. Wholesalers and Distributors
3.5.2. Value Added and Value Created at Node in the Supply Chain
3.5.3. List of Raw Material Suppliers
3.5.4. List of Existing and Potential Buyer’s
3.6. Investment Feasibility Matrix
3.7. Value Chain Analysis
3.7.1. Profit Margin Analysis
3.7.2. Wholesalers and Distributors
3.7.3. Retailers
3.8. PESTLE and Porter’s Analysis
3.9. Regulatory Landscape
3.9.1. By Key Regions
3.9.2. By Key Countries
3.10. Regional Parent Market Outlook
3.11. Production and Consumption Statistics
3.12. Import and Export Statistics
4. Global Market Analysis 2017-2021 and Forecast, 2022-2032
4.1. Historical Market Size Value (US$ Mn) & Volume (Tons) Analysis, 2017-2021
4.2. Current and Future Market Size Value (US$ Mn) & Volume (Tons) Projections, 2022-2032
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. Global Market Analysis 2017-2021 and Forecast 2022-2032, By Source
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ Mn) & Volume (Tons) Analysis By Source, 2017-2021
5.3. Current and Future Market Size Value (US$ Mn) & Volume (Tons) Analysis and Forecast By Source, 2022-2032
5.3.1. Holy Basil (Tulsi)
5.3.2. Bilberry
5.3.3. Devil’s Claw
5.3.4. Elderflowers
5.3.5. Peppermint Leaves
5.3.6. Periwinkle
5.3.7. Lavender
5.3.8. Oregano
5.3.9. Thyme
5.3.10. Hawthorn
5.3.11. Cherry Laurel Leaves
5.4. Y-o-Y Growth Trend Analysis By Source, 2017-2021
5.5. Absolute $ Opportunity Analysis By Source, 2022-2032
6. Global Market Analysis 2017-2021 and Forecast 2022-2032, By Industry
6.1. Introduction / Key Findings
6.2. Historical Market Size Value (US$ Mn) & Volume (Tons) Analysis By Industry, 2017-2021
6.3. Current and Future Market Size Value (US$ Mn) & Volume (Tons) Analysis and Forecast By Industry, 2022-2032
6.3.1. Food
6.3.2. Beverage
6.3.3. Pharmaceutical
6.3.4. Cosmetics
6.3.5. Nutraceutical
6.4. Y-o-Y Growth Trend Analysis By Industry, 2017-2021
6.5. Absolute $ Opportunity Analysis By Industry, 2022-2032
7. Global Market Analysis 2017-2021 and Forecast 2022-2032, By Form
7.1. Introduction / Key Findings
7.2. Historical Market Size Value (US$ Mn) & Volume (Tons) Analysis By Form, 2017-2021
7.3. Current and Future Market Size Value (US$ Mn) & Volume (Tons) Analysis and Forecast By Form, 2022-2032
7.3.1. Powdered
7.3.2. Capsules
7.3.3. Liquid
7.4. Y-o-Y Growth Trend Analysis By Form, 2017-2021
7.5. Absolute $ Opportunity Analysis By Form, 2022-2032
8. Global Market Analysis 2017-2021 and Forecast 2022-2032, By Type
8.1. Introduction / Key Findings
8.2. Historical Market Size Value (US$ Mn) & Volume (Tons) Analysis By Type, 2017-2021
8.3. Current and Future Market Size Value (US$ Mn) & Volume (Tons) Analysis and Forecast By Type, 2022-2032
8.3.1. 25% Ursolic Acid
8.3.2. 50% Ursolic Acid
8.3.3. 90% Ursolic Acid
8.3.4. 98% Ursolic Acid
8.3.5. Others
8.4. Y-o-Y Growth Trend Analysis By Type, 2017-2021
8.5. Absolute $ Opportunity Analysis By Type, 2022-2032
9. Global Market Analysis 2017-2021 and Forecast 2022-2032, By Region
9.1. Introduction
9.2. Historical Market Size Value (US$ Mn) & Volume (Tons) Analysis By Region, 2017-2021
9.3. Current Market Size Value (US$ Mn) & Volume (Tons) Analysis and Forecast By Region, 2022-2032
9.3.1. North America
9.3.2. Latin America
9.3.3. Europe
9.3.4. Asia Pacific
9.3.5. MEA
9.4. Market Attractiveness Analysis By Region
10. North America Market Analysis 2017-2021 and Forecast 2022-2032, By Country
10.1. Historical Market Size Value (US$ Mn) & Volume (Tons) Trend Analysis By Market Taxonomy, 2017-2021
10.2. Market Size Value (US$ Mn) & Volume (Tons) Forecast By Market Taxonomy, 2022-2032
10.2.1. By Country
10.2.1.1. U.S.
10.2.1.2. Canada
10.2.2. By Source
10.2.3. By Industry
10.2.4. By Form
10.2.5. By Type
10.3. Market Attractiveness Analysis
10.3.1. By Country
10.3.2. By Source
10.3.3. By Industry
10.3.4. By Form
10.3.5. By Type
10.4. Key Takeaways
11. Latin America Market Analysis 2017-2021 and Forecast 2022-2032, By Country
11.1. Historical Market Size Value (US$ Mn) & Volume (Tons) Trend Analysis By Market Taxonomy, 2017-2021
11.2. Market Size Value (US$ Mn) & Volume (Tons) Forecast By Market Taxonomy, 2022-2032
11.2.1. By Country
11.2.1.1. Brazil
11.2.1.2. Mexico
11.2.1.3. Rest of Latin America
11.2.2. By Source
11.2.3. By Industry
11.2.4. By Form
11.2.5. By Type
11.3. Market Attractiveness Analysis
11.3.1. By Country
11.3.2. By Source
11.3.3. By Industry
11.3.4. By Form
11.3.5. By Type
11.4. Key Takeaways
12. Europe Market Analysis 2017-2021 and Forecast 2022-2032, By Country
12.1. Historical Market Size Value (US$ Mn) & Volume (Tons) Trend Analysis By Market Taxonomy, 2017-2021
12.2. Market Size Value (US$ Mn) & Volume (Tons) Forecast By Market Taxonomy, 2022-2032
12.2.1. By Country
12.2.1.1. Germany
12.2.1.2. U.K.
12.2.1.3. France
12.2.1.4. Spain
12.2.1.5. Italy
12.2.1.6. Rest of Europe
12.2.2. By Source
12.2.3. By Industry
12.2.4. By Form
12.2.5. By Type
12.3. Market Attractiveness Analysis
12.3.1. By Country
12.3.2. By Source
12.3.3. By Industry
12.3.4. By Form
12.3.5. By Type
12.4. Key Takeaways
13. Asia Pacific Market Analysis 2017-2021 and Forecast 2022-2032, By Country
13.1. Historical Market Size Value (US$ Mn) & Volume (Tons) Trend Analysis By Market Taxonomy, 2017-2021
13.2. Market Size Value (US$ Mn) & Volume (Tons) Forecast By Market Taxonomy, 2022-2032
13.2.1. By Country
13.2.1.1. China
13.2.1.2. Japan
13.2.1.3. South Korea
13.2.1.4. Malaysia
13.2.1.5. Singapore
13.2.1.6. Australia
13.2.1.7. New Zealand
13.2.1.8. Rest of APAC
13.2.2. By Source
13.2.3. By Industry
13.2.4. By Form
13.2.5. By Type
13.3. Market Attractiveness Analysis
13.3.1. By Country
13.3.2. By Source
13.3.3. By Industry
13.3.4. By Form
13.3.5. By Type
13.4. Key Takeaways
14. MEA Market Analysis 2017-2021 and Forecast 2022-2032, By Country
14.1. Historical Market Size Value (US$ Mn) & Volume (Tons) Trend Analysis By Market Taxonomy, 2017-2021
14.2. Market Size Value (US$ Mn) & Volume (Tons) Forecast By Market Taxonomy, 2022-2032
14.2.1. By Country
14.2.1.1. GCC Countries
14.2.1.2. South Africa
14.2.1.3. Israel
14.2.1.4. Rest of MEA
14.2.2. By Source
14.2.3. By Industry
14.2.4. By Form
14.2.5. By Type
14.3. Market Attractiveness Analysis
14.3.1. By Country
14.3.2. By Source
14.3.3. By Industry
14.3.4. By Form
14.3.5. By Type
14.4. Key Takeaways
15. Key Countries Market Analysis
15.1. U.S.
15.1.1. Pricing Analysis
15.1.2. Market Share Analysis, 2021
15.1.2.1. By Source
15.1.2.2. By Industry
15.1.2.3. By Form
15.1.2.4. By Type
15.2. Canada
15.2.1. Pricing Analysis
15.2.2. Market Share Analysis, 2021
15.2.2.1. By Source
15.2.2.2. By Industry
15.2.2.3. By Form
15.2.2.4. By Type
15.3. Brazil
15.3.1. Pricing Analysis
15.3.2. Market Share Analysis, 2021
15.3.2.1. By Source
15.3.2.2. By Industry
15.3.2.3. By Form
15.3.2.4. By Type
15.4. Mexico
15.4.1. Pricing Analysis
15.4.2. Market Share Analysis, 2021
15.4.2.1. By Source
15.4.2.2. By Industry
15.4.2.3. By Form
15.4.2.4. By Type
15.5. Germany
15.5.1. Pricing Analysis
15.5.2. Market Share Analysis, 2021
15.5.2.1. By Source
15.5.2.2. By Industry
15.5.2.3. By Form
15.5.2.4. By Type
15.6. U.K.
15.6.1. Pricing Analysis
15.6.2. Market Share Analysis, 2021
15.6.2.1. By Source
15.6.2.2. By Industry
15.6.2.3. By Form
15.6.2.4. By Type
15.7. France
15.7.1. Pricing Analysis
15.7.2. Market Share Analysis, 2021
15.7.2.1. By Source
15.7.2.2. By Industry
15.7.2.3. By Form
15.7.2.4. By Type
15.8. Spain
15.8.1. Pricing Analysis
15.8.2. Market Share Analysis, 2021
15.8.2.1. By Source
15.8.2.2. By Industry
15.8.2.3. By Form
15.8.2.4. By Type
15.9. Italy
15.9.1. Pricing Analysis
15.9.2. Market Share Analysis, 2021
15.9.2.1. By Source
15.9.2.2. By Industry
15.9.2.3. By Form
15.9.2.4. By Type
15.10. China
15.10.1. Pricing Analysis
15.10.2. Market Share Analysis, 2021
15.10.2.1. By Source
15.10.2.2. By Industry
15.10.2.3. By Form
15.10.2.4. By Type
15.11. Japan
15.11.1. Pricing Analysis
15.11.2. Market Share Analysis, 2021
15.11.2.1. By Source
15.11.2.2. By Industry
15.11.2.3. By Form
15.11.2.4. By Type
15.12. South Korea
15.12.1. Pricing Analysis
15.12.2. Market Share Analysis, 2021
15.12.2.1. By Source
15.12.2.2. By Industry
15.12.2.3. By Form
15.12.2.4. By Type
15.13. Malaysia
15.13.1. Pricing Analysis
15.13.2. Market Share Analysis, 2021
15.13.2.1. By Source
15.13.2.2. By Industry
15.13.2.3. By Form
15.13.2.4. By Type
15.14. Singapore
15.14.1. Pricing Analysis
15.14.2. Market Share Analysis, 2021
15.14.2.1. By Source
15.14.2.2. By Industry
15.14.2.3. By Form
15.14.2.4. By Type
15.15. Australia
15.15.1. Pricing Analysis
15.15.2. Market Share Analysis, 2021
15.15.2.1. By Source
15.15.2.2. By Industry
15.15.2.3. By Form
15.15.2.4. By Type
15.16. New Zealand
15.16.1. Pricing Analysis
15.16.2. Market Share Analysis, 2021
15.16.2.1. By Source
15.16.2.2. By Industry
15.16.2.3. By Form
15.16.2.4. By Type
15.17. GCC Countries
15.17.1. Pricing Analysis
15.17.2. Market Share Analysis, 2021
15.17.2.1. By Source
15.17.2.2. By Industry
15.17.2.3. By Form
15.17.2.4. By Type
15.18. South Africa
15.18.1. Pricing Analysis
15.18.2. Market Share Analysis, 2021
15.18.2.1. By Source
15.18.2.2. By Industry
15.18.2.3. By Form
15.18.2.4. By Type
15.19. Israel
15.19.1. Pricing Analysis
15.19.2. Market Share Analysis, 2021
15.19.2.1. By Source
15.19.2.2. By Industry
15.19.2.3. By Form
15.19.2.4. By Type
16. Market Structure Analysis
16.1. Competition Dashboard
16.2. Competition Benchmarking
16.3. Market Share Analysis of Top Players
16.3.1. By Regional
16.3.2. By Source
16.3.3. By Industry
16.3.4. By Form
16.3.5. By Type
17. Competition Analysis
17.1. Competition Deep Dive
17.1.1. Sabinsa
17.1.1.1. Overview
17.1.1.2. Product Portfolio
17.1.1.3. Profitability by Market Segments
17.1.1.4. Sales Footprint
17.1.1.5. Strategy Overview
17.1.1.5.1. Marketing Strategy
17.1.1.5.2. Product Strategy
17.1.1.5.3. Channel Strategy
17.1.2. Changsha Staherb Natural Ingredients
17.1.2.1. Overview
17.1.2.2. Product Portfolio
17.1.2.3. Profitability by Market Segments
17.1.2.4. Sales Footprint
17.1.2.5. Strategy Overview
17.1.2.5.1. Marketing Strategy
17.1.2.5.2. Product Strategy
17.1.2.5.3. Channel Strategy
17.1.3. Changsha Luyuan Bio-Tech
17.1.3.1. Overview
17.1.3.2. Product Portfolio
17.1.3.3. Profitability by Market Segments
17.1.3.4. Sales Footprint
17.1.3.5. Strategy Overview
17.1.3.5.1. Marketing Strategy
17.1.3.5.2. Product Strategy
17.1.3.5.3. Channel Strategy
17.1.4. Run Shaanxi Days of Bio-tech
17.1.4.1. Overview
17.1.4.2. Product Portfolio
17.1.4.3. Profitability by Market Segments
17.1.4.4. Sales Footprint
17.1.4.5. Strategy Overview
17.1.4.5.1. Marketing Strategy
17.1.4.5.2. Product Strategy
17.1.4.5.3. Channel Strategy
17.1.5. Shaanxi Hopeland Chem-Tech
17.1.5.1. Overview
17.1.5.2. Product Portfolio
17.1.5.3. Profitability by Market Segments
17.1.5.4. Sales Footprint
17.1.5.5. Strategy Overview
17.1.5.5.1. Marketing Strategy
17.1.5.5.2. Product Strategy
17.1.5.5.3. Channel Strategy
17.1.6. Xuancheng Baicao Pharmaceutical
17.1.6.1. Overview
17.1.6.2. Product Portfolio
17.1.6.3. Profitability by Market Segments
17.1.6.4. Sales Footprint
17.1.6.5. Strategy Overview
17.1.6.5.1. Marketing Strategy
17.1.6.5.2. Product Strategy
17.1.6.5.3. Channel Strategy
17.1.7. Acetar Bio-Tech
17.1.7.1. Overview
17.1.7.2. Product Portfolio
17.1.7.3. Profitability by Market Segments
17.1.7.4. Sales Footprint
17.1.7.5. Strategy Overview
17.1.7.5.1. Marketing Strategy
17.1.7.5.2. Product Strategy
17.1.7.5.3. Channel Strategy
17.1.8. Changsha E.K HERB
17.1.8.1. Overview
17.1.8.2. Product Portfolio
17.1.8.3. Profitability by Market Segments
17.1.8.4. Sales Footprint
17.1.8.5. Strategy Overview
17.1.8.5.1. Marketing Strategy
17.1.8.5.2. Product Strategy
17.1.8.5.3. Channel Strategy
17.1.9. Hunan NutraMax
17.1.9.1. Overview
17.1.9.2. Product Portfolio
17.1.9.3. Profitability by Market Segments
17.1.9.4. Sales Footprint
17.1.9.5. Strategy Overview
17.1.9.5.1. Marketing Strategy
17.1.9.5.2. Product Strategy
17.1.9.5.3. Channel Strategy
17.1.10. Xi’an TonKing
17.1.10.1. Overview
17.1.10.2. Product Portfolio
17.1.10.3. Profitability by Market Segments
17.1.10.4. Sales Footprint
17.1.10.5. Strategy Overview
17.1.10.5.1. Marketing Strategy
17.1.10.5.2. Product Strategy
17.1.10.5.3. Channel Strategy
17.1.11. MicroHerb
17.1.11.1. Overview
17.1.11.2. Product Portfolio
17.1.11.3. Profitability by Market Segments
17.1.11.4. Sales Footprint
17.1.11.5. Strategy Overview
17.1.11.5.1. Marketing Strategy
17.1.11.5.2. Product Strategy
17.1.11.5.3. Channel Strategy
17.1.12. Geneham Pharmaceutical
17.1.12.1. Overview
17.1.12.2. Product Portfolio
17.1.12.3. Profitability by Market Segments
17.1.12.4. Sales Footprint
17.1.12.5. Strategy Overview
17.1.12.5.1. Marketing Strategy
17.1.12.5.2. Product Strategy
17.1.12.5.3. Channel Strategy
18. Assumptions & Acronyms Used
19. Research Methodology
Explore Food and Beverage Insights
View Reports
Ursolic Acid Market
